
HQ - Harwell, Oxfordshire
Summary
Barinthus Biotherapeutics plc (NASDAQ: BRNS) (“Barinthus Bio”) is an immunology and inflammation company focused on developing therapies that promote immune tolerance
Deals Overview
All rights reserved. Copyright © 2025 Datasite
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
Senior Management
Bill Enright
CEO